Low-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-05-04
DOI
10.3389/fphar.2017.00244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect
- (2016) Xi-sha Chen et al. ACTA PHARMACOLOGICA SINICA
- Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response
- (2016) Kheshwant S. Gill et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target
- (2016) M. Bolzoni et al. BLOOD
- Heat shock protein 70–2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth
- (2016) Nirmala Jagadish et al. BMC CANCER
- STAT3-dependent TXNDC17 expression mediates Taxol resistance through inducing autophagy in human colorectal cancer cells
- (2016) Zhongde Zhang et al. GENE
- Nitric oxide and pH modulation in gynaecological cancer
- (2016) Carlos Sanhueza et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences
- (2016) Delisha A. Stewart et al. JOURNAL OF PROTEOME RESEARCH
- Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy
- (2016) Natalie A. Duggett et al. NEUROSCIENCE
- Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
- (2016) Florence Polet et al. Oncotarget
- Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
- (2016) Jiaolin Zhou et al. PLoS One
- Expression of Metabolism-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma
- (2015) Ja Seung Koo et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- p27Kip1and p21Cip1collaborate in the regulation of transcription by recruiting cyclin–Cdk complexes on the promoters of target genes
- (2015) Serena Orlando et al. NUCLEIC ACIDS RESEARCH
- Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy
- (2015) Anna Barbuti et al. Cancers
- Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
- (2014) Kodappully Sivaraman Siveen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Geroncogenesis: Metabolic Changes during Aging as a Driver of Tumorigenesis
- (2014) Lindsay E. Wu et al. CANCER CELL
- E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation
- (2014) Zijia Ren et al. Molecular Cancer
- Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
- (2014) Li-Hua Gong et al. Oxidative Medicine and Cellular Longevity
- Management of Hypersensitivity Reactions to Carboplatin and Paclitaxel in an Outpatient Oncology Infusion Center: A 5-Year Review
- (2014) Aleena Banerji et al. Journal of Allergy and Clinical Immunology-In Practice
- The pharmacological bases of the antiangiogenic activity of paclitaxel
- (2013) Guido Bocci et al. ANGIOGENESIS
- Low-dose metronomic chemotherapy: A systematic literature analysis
- (2013) K. Lien et al. EUROPEAN JOURNAL OF CANCER
- Cancer metabolism: Key players in metabolic reprogramming
- (2012) Tomoyoshi Soga CANCER SCIENCE
- Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancer
- (2012) David Loven et al. DRUG DISCOVERY TODAY
- Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells
- (2012) YUNG HYUN CHOI et al. ONCOLOGY REPORTS
- Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments
- (2011) N. Draoui et al. Disease Models & Mechanisms
- Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia
- (2011) Hsiu-Ni Kung et al. PLoS Genetics
- Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in Mice
- (2009) Hongchi Jiang et al. CANCER INVESTIGATION
- The glutamate homeostasis hypothesis of addiction
- (2009) Peter W. Kalivas NATURE REVIEWS NEUROSCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started